Effectiveness Testing of a Videogame Intervention (No Baby No) to Decrease Contraception Non-use Among Adolescents.
2 other identifiers
interventional
850
1 country
7
Brief Summary
The purpose of this study is to evaluate the effectiveness of a videogame compared to an attention/time control at reducing contraceptive non-use among adolescents.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2025
Typical duration for not_applicable
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 15, 2025
CompletedFirst Posted
Study publicly available on registry
May 25, 2025
CompletedStudy Start
First participant enrolled
June 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2027
December 22, 2025
December 1, 2025
2.4 years
May 15, 2025
December 15, 2025
Conditions
Outcome Measures
Primary Outcomes (10)
Change in mean frequency of participants' contraception non-use over the last 3 months.
Change in mean frequency of how often participants had penile/vaginal sex without a condom or birth control (pregnancy prevention), as self-reported on a customized survey with multiple-choice questions adapted from the Youth Risk Behavior Survey (YRBS). Scale values range from once to five or more times, with higher scores indicating a "worse" outcome. Scores are not being reported. At baseline, 2 weeks, and 9-month follow-up participants will be asked about the prior 3 months.
Baseline, 3-month follow-up, 9-month follow-up.
Change in mean frequency of participants' contraception non-use at last sexual encounter.
Change in mean frequency of how often participants had penile/vaginal sex without a condom or birth control (pregnancy prevention), as self-reported on a customized survey with multiple-choice questions adapted from the Youth Risk Behavior Survey (YRBS). Scale values range from once to five or more times, with higher scores indicating a "worse" outcome. Scores are not being reported. At baseline, 2 weeks, and 9-month follow-up participants will be asked about their last sexual encounter.
Baseline, 3-month follow-up, 9-month follow-up.
Change in participants' use of different types of contraception over the last 3 months.
A change in the mean use of less effective- (withdrawal, condom with or without spermicide, spermicide alone, fertility-based awareness, diaphragm, sponge), more effective- (pill, patch, vaginal ring, injection, intrauterine device, implant), and dual method (condom + other) contraception use during sexual encounters as self-reported on a customized survey with multiple-choice questions adapted from the Youth Risk Behavior Survey (YRBS). Participants select all forms of contraception that they used, with response options also including "No method was used to prevent pregnancy or STIs". At baseline, 2 weeks, and 9-month follow-up participants will be asked about the prior 3 months
Baseline, 3-month follow-up, 9-month follow-up.
Change in participants' use of different types of contraception at last sexual encounter.
A change in the mean use of less effective- (withdrawal, condom with or without spermicide, spermicide alone, fertility-based awareness, diaphragm, sponge), more effective- (pill, patch, vaginal ring, injection, intrauterine device, implant), and dual method (condom + other) contraception use during sexual encounters as self-reported on a customized survey with multiple-choice questions adapted from the Youth Risk Behavior Survey (YRBS). At baseline, 2 weeks, and 9-month follow-up participants will be asked about their last sexual encounter.
Baseline, 3-month follow-up, 9-month follow-up.
Change in number of participants abstaining from having sex over the last 3 months.
A change in the number of participants who abstained from having sex as self-reported on a customized survey with multiple-choice questions adapted from the Youth Risk Behavior Survey (YRBS). At baseline, 2 weeks, and 9-month follow-up participants will be asked about the prior 3 months.
Baseline, 3-month follow-up, 9-month follow-up.
Change in the mean number of sexual encounters over the last 3 months.
A change in the mean number of times participants had penile/vaginal sex as self-reported on a customized survey with a multiple-choice survey question adapted from the Youth Risk Behavior Survey (YRBS). At baseline, 2 weeks, and 9-month follow-up participants will be asked about the prior 3 months.
Baseline, 3-month follow-up, 9-month follow-up.
Change in the mean number of sexual partners over the last 3 months.
A change in participants mean number of self-reported sexual partners, as reflected by their answer to a multiple-choice survey question adapted from the Youth Risk Behavior Survey (YRBS). At baseline, 2 weeks, and 9-month follow-up participants will be asked about the prior 3 months.
Baseline, 3-month follow-up, 9-month follow-up.
Change in the number of participants who use alcohol and/or take drugs before sex at last sexual encounter.
Change in the number of participants who self-report drinking alcohol or using drugs before having sex, based on Yes/No responses to a question adapted from the Youth Risk Behavior Survey (YRBS). At baseline, 2 weeks, and 9-month follow-up participants will be asked about the last sexual encounter.
Baseline, 3-month follow-up, 9-month follow-up.
Change in the number of participants with a positive STI (Sexually Transmitted infection) test result.
A change in the number of participants who self-report ever receiving a positive STI result on a customized survey as adapted by YRBSS Questionnaire. At baseline, 2 weeks, and 9-month follow-up participants will be asked if they have ever received a positive STI (Sexually Transmitted infection) test result.
Baseline, 3-month follow-up, 9-month follow-up.
Change in the number of participants with a positive pregnancy test result for themselves or a partner.
A change in the number of participants who self-report ever receiving a positive pregnancy test result or report their partner ever receiving a positive pregnancy test result, as documented by a Yes/No question on a customized survey. At baseline, 2 weeks, and 9-month follow-up participants will be asked if they/their partner have ever received a positive pregnancy test result.
Baseline, 3-month follow-up, 9-month follow-up.
Secondary Outcomes (21)
Change in participants' intentions for contraception non-use over the next year, as indicated by participants' mean responses to a survey question.
Baseline, 3-month follow-up, 9-month follow-up.
Change in participants' self-efficacy regarding condom use, as indicated by their mean rating on a survey question.
Baseline, 3-month follow-up, 9-month follow-up.
Change in participants' self-efficacy regarding contraception use, as indicated by their mean ratings on a survey question.
Baseline, 3-month follow-up, 9-month follow-up.
Change in participants' perceptions of sexual risk (susceptibility to getting an STI), as indicated by their mean rating on a survey question.
Baseline, 3-month follow-up, 9-month follow-up.
Change in participants' perceptions of sexual risk (getting pregnant/getting a partner pregnant), as indicated by their mean rating on a survey question.
Baseline, 3-month follow-up, 9-month follow-up.
- +16 more secondary outcomes
Study Arms (2)
No Baby No Videogame Intervention
EXPERIMENTALParticipants randomized to video game intervention for 120 minutes over two sessions within two weeks.
Commercial game control
SHAM COMPARATORParticipants randomized to commercial game intervention for 120 minutes over two sessions within two weeks.
Interventions
Eligibility Criteria
You may qualify if:
- Male or Female
- Age15-20 at the time of enrollment
- Able to speak and read English or Spanish
- Have a smart phone (to scan QR code) or personal email account (to take screening questionnaire)
You may not qualify if:
- Age less than 15 or older than 20
- Unable to speak and read English or Spanish
- Do not have a smart phone or personal email account
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
Sesame Flyers International Inc.
Brooklyn, New York, 11203, United States
El Barrio Operation Fightback
New York, New York, 10035, United States
King of Kings Foundation
Queens, New York, 11433, United States
New York Center for Interpersonal Development (NYCID)
Staten Island, New York, 10301, United States
Bronx Health Link
The Bronx, New York, 10451, United States
ASPIRA
The Bronx, New York, 10454, United States
Destination Tomorrow
The Bronx, New York, 10455, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aileen Gariepy, MD, MPH, MHS
Weill Medical College of Cornell University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 15, 2025
First Posted
May 25, 2025
Study Start
June 11, 2025
Primary Completion (Estimated)
November 1, 2027
Study Completion (Estimated)
November 1, 2027
Last Updated
December 22, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share